Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 1
2003 1
2005 1
2006 3
2007 2
2008 5
2009 4
2010 6
2011 6
2012 16
2013 5
2014 9
2015 15
2016 20
2017 19
2018 29
2019 28
2020 31
2021 35
2022 30
2023 18
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D. Leweke FM, et al. Transl Psychiatry. 2012 Mar 20;2(3):e94. doi: 10.1038/tp.2012.15. Transl Psychiatry. 2012. PMID: 22832859 Free PMC article. Clinical Trial.
In our translational approach, we performed a double-blind, randomized clinical trial of cannabidiol vs amisulpride, a potent antipsychotic, in acute schizophrenia to evaluate the clinical relevance of our initial findings. ...The results suggest that inhibition of …
In our translational approach, we performed a double-blind, randomized clinical trial of cannabidiol vs amisulpride, a potent antipsy …
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. García-Gutiérrez MS, et al. Biomolecules. 2020 Nov 19;10(11):1575. doi: 10.3390/biom10111575. Biomolecules. 2020. PMID: 33228239 Free PMC article. Review.
Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD displays an interesting pharmacological profile without the potential for becoming a drug of abuse, unlike THC. ...
Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD displa …
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies.
Schoevers J, Leweke JE, Leweke FM. Schoevers J, et al. Curr Opin Psychiatry. 2020 May;33(3):185-191. doi: 10.1097/YCO.0000000000000596. Curr Opin Psychiatry. 2020. PMID: 32073423 Review.
PURPOSE OF REVIEW: The most recent studies published or initiated in the last 18 months, investigating cannabidiol in the treatment of symptoms of schizophrenia and related conditions are summarized, including observed tolerability and reported side-effects. ...SUMM …
PURPOSE OF REVIEW: The most recent studies published or initiated in the last 18 months, investigating cannabidiol in the treatment o …
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Shannon S, Lewis N, Lee H, Hughes S. Shannon S, et al. Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041. Perm J. 2019. PMID: 30624194 Free PMC article.
CONTEXT: Cannabidiol (CBD) is one of many cannabinoid compounds found in cannabis. ...In this chart review, CBD was well tolerated in all but 3 patients. CONCLUSION: Cannabidiol may hold benefit for anxiety-related disorders. Controlled clinical studies are needed.. …
CONTEXT: Cannabidiol (CBD) is one of many cannabinoid compounds found in cannabis. ...In this chart review, CBD was well tolerated in …
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.
To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders. ...CBD bears investigation in epilepsy and other neuropsychiatric disorders, including anxie …
To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to epilepsy …
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM. White CM. J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7. J Clin Pharmacol. 2019. PMID: 30730563 Review.
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...Acute CBD dosing before anxiety-provoking events like public speaking and the chronic use of CBD in schizophrenia are promising but not proven. CBD is not risk free, wi …
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...Acute CBD dosing before anxiety-pro …
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA, Hallak JEC, Abílio VC. Loss CM, et al. Front Pharmacol. 2021 Feb 4;11:635763. doi: 10.3389/fphar.2020.635763. eCollection 2020. Front Pharmacol. 2021. PMID: 33613289 Free PMC article. Review.
Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental disorders that cause high levels of functional disabilities. ...Therefore, the search for treatments that could be beneficial for the altered course of the neurodevelopment associated with …
Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental disorders that cause high levels of functional d …
The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review.
Patel S, Khan S, M S, Hamid P. Patel S, et al. Cureus. 2020 Jul 21;12(7):e9309. doi: 10.7759/cureus.9309. Cureus. 2020. PMID: 32839678 Free PMC article. Review.
Schizophrenia is a chronic illness affecting approximately 20 million people worldwide. ...Six studies had data supporting the therapeutic effect of the cannabidiol (CBD) component of cannabis. From the current data, we can conclude that the tetrahydrocannabinol (TH …
Schizophrenia is a chronic illness affecting approximately 20 million people worldwide. ...Six studies had data supporting the therap …
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Garakani A, et al. Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. eCollection 2020. Front Psychiatry. 2020. PMID: 33424664 Free PMC article. Review.
While there continues to be expansive research in posttraumatic stress disorder (PTSD), depression and schizophrenia, there is a relative dearth of novel medications under investigation for anxiety disorders. ...Although there are some recent randomized controlled trials f …
While there continues to be expansive research in posttraumatic stress disorder (PTSD), depression and schizophrenia, there is a rela …
Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment.
Ghabrash MF, Coronado-Montoya S, Aoun J, Gagné AA, Mansour F, Ouellet-Plamondon C, Trépanier A, Jutras-Aswad D. Ghabrash MF, et al. Psychiatry Res. 2020 Feb 21;286:112890. doi: 10.1016/j.psychres.2020.112890. Online ahead of print. Psychiatry Res. 2020. PMID: 32126328 Review.
This systematic review examines the use of cannabidiol as an antipsychotic treatment for primary psychotic disorders. ...Cannabidiol treatment had an advantageous side effect profile compared to other antipsychotics and was well tolerated across studies. ...
This systematic review examines the use of cannabidiol as an antipsychotic treatment for primary psychotic disorders. ...Cannabidi …
257 results